Hybrid planning techniques for early-stage left-sided breast cancer: dose distribution analysis and estimation of projected secondary cancer-relative risk

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi: 10.1016/j.breast.2022.08.010.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi: 10.1016/S0140-6736(17)33326-3.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716. doi: 10.1016/S0140-6736(11)61629-2.
   PubMed Web of Science ®Google Scholar
• Vikström J, Hjelstuen MH, Mjaaland I, et al. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol. 2011;50(1):42–50. doi: 10.3109/0284186X.2010.512923.
   PubMed Web of Science ®Google Scholar
• Hjelstuen MH, Mjaaland I, Vikström J, et al. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol. 2012;51(3):333–344. doi: 10.3109/0284186X.2011.618510.
   PubMed Web of Science ®Google Scholar
• Berg M, Lorenzen EL, Jensen I, et al. The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial. Acta Oncol. 2018;57(1):113–119. doi: 10.1080/0284186X.2017.1406139.
   PubMed Web of Science ®Google Scholar
• Vikström J, Hjelstuen MH, Wasbø E, et al. A comparison of conventional and dynamic radiotherapy planning techniques for early-stage breast cancer utilizing deep inspiration breath-hold. Acta Oncol. 2018;57(10):1325–1330. doi: 10.1080/0284186X.2018.1497294.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhu X, Zhang M, et al. Estimation of internal organ motion-induced variance in radiation dose in non-gated radiotherapy. Phys Med Biol. 2016;61(23):8157–8179. doi: 10.1088/0031-9155/61/23/8157.
   PubMed Web of Science ®Google Scholar
• Ramasubramanian V, Balaji K, Balaji Subramanian S, et al. Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs. Radiol Med. 2019;124(6):546–554. doi: 10.1007/s11547-019-00994-1.
   PubMed Web of Science ®Google Scholar
• Michalski A, Atyeo J, Cox J, et al. Inter- and intra-fraction motion during radiation therapy to the whole breast in the supine position: a systematic review. J Med Imaging Radiat Oncol. 2012;56(5):499–509. doi: 10.1111/j.1754-9485.2012.02434.x.
   PubMed Web of Science ®Google Scholar
• Moon SH, Shin KH, Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol. 2009;90(1):66–73. doi: 10.1016/j.radonc.2008.09.027.
   PubMed Web of Science ®Google Scholar
• Beckham WA, Popescu CC, Patenaude VV, et al. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys. 2007;69(3):918–924. doi: 10.1016/j.ijrobp.2007.06.060.
   PubMed Web of Science ®Google Scholar
• Haciislamoglu E, Cinar Y, Gurcan F, et al. Secondary cancer risk after whole-breast radiation therapy: field-in-field versus intensity modulated radiation therapy versus volumetric modulated arc therapy. Br J Radiol. 2019;92(1102):20190317. doi: 10.1259/bjr.20190317.
   PubMed Web of Science ®Google Scholar
• Lee B, Lee S, Sung J, et al. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT. J Radiol Prot. 2014;34(2):325–331. doi: 10.1088/0952-4746/34/2/325.
   PubMed Web of Science ®Google Scholar
• Paganetti H. Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy. Health Phys. 2012;103(5):652–661. doi: 10.1097/HP.0b013e318261113d.
   PubMed Web of Science ®Google Scholar
• National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington DC: The National Academies Press; 2006.
   Google Scholar
• Mayo CS, Urie MM, Fitzgerald TJ. Hybrid IMRT plans–concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys. 2005;61(3):922–932. doi: 10.1016/j.ijrobp.2004.10.033.
   PubMed Web of Science ®Google Scholar
• Lin JF, Yeh DC, Yeh HL, et al. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer. Med Dosim. 2015;40(3):262–267. doi: 10.1016/j.meddos.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Jöst V, Kretschmer M, Sabatino M, et al. Heart dose reduction in breast cancer treatment with simultaneous integrated boost. Strahlenther Onkol. 2015;191(9):734–741. doi: 10.1007/s00066-015-0874-7.
   PubMed Web of Science ®Google Scholar
• Chen YG, Li AC, Li WY, et al. The feasibility study of a hybrid coplanar arc technique Versus hybrid intensity-modulated radiotherapy in treatment of early-stage left-sided breast cancer with simultaneous-integrated boost. J Med Phys. 2017;42(1):1–8. doi: 10.4103/jmp.JMP_105_16.
   PubMedGoogle Scholar
• Bi S, Zhu R, Dai Z. Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT. Radiat Oncol. 2022;17(1):60. doi: 10.1186/s13014-022-02009-2.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zeng Y, Peng Y, et al. Critical evaluation of secondary cancer risk after breast radiation therapy with hybrid radiotherapy techniques. Breast Cancer. 2023;15:25–38. doi: 10.2147/BCTT.S383369.
   PubMed Web of Science ®Google Scholar
• Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3–10. doi: 10.1016/j.radonc.2014.11.030.
   PubMed Web of Science ®Google Scholar
• Schneider U. Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys. 2009;36(4):1138–1143. doi: 10.1118/1.3089792.
   PubMed Web of Science ®Google Scholar
• Schneider U, Sumila M, Robotka J. Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model. 2011;8:27. doi: 10.1186/1742-4682-8-27.
   PubMed Web of Science ®Google Scholar
• ICRU. Report 83. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRP. 2010;10(1):34–36. doi: 10.1093/jicru/ndq002.
   Google Scholar
• Lang K, Loritz B, Schwartz A, et al. Dosimetric comparison between volumetric-modulated arc therapy and a hybrid volumetric-modulated arc therapy and segmented field-in-field technique for postmastectomy chest wall and regional lymph node irradiation. Med Dosim. 2020;45(2):121–127. doi: 10.1016/j.meddos.2019.08.001.
   PubMed Web of Science ®Google Scholar
• Bi S, Zhu R, Sun X, et al. Dosimetric comparison of IMRT, hybrid IMRT and hybrid VMAT for early stage right-sided breast cancer. Clin Oncol. 2021;6:1808.
   Google Scholar
• Jeulink M, Dahele M, Meijnen P, et al. Is there a preferred IMRT technique for left-breast irradiation? J Appl Clin Med Phys. 2015;16(3):5266.
   PubMed Web of Science ®Google Scholar
• Racka I, Majewska K, Winiecki J. Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk. Strahlenther Onkol. 2023;199(1):90–101. doi: 10.1007/s00066-022-01979-2.
   PubMed Web of Science ®Google Scholar
• Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1–7. doi: 10.1016/j.ijrobp.2006.01.027.
   PubMed Web of Science ®Google Scholar
• Clemente S, Cozzolino M, Chiumento C, et al. Monitor unit optimization in RapidArc plans for prostate cancer. J Appl Clin Med Phys. 2013;14(3):4114.
   PubMed Web of Science ®Google Scholar
• Balaji K, Balaji Subramanian S, Sathiya K, et al. Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams. Strahlenther Onkol. 2020;196(4):376–385. doi: 10.1007/s00066-019-01555-1.
   PubMed Web of Science ®Google Scholar
• Balaji K, Ramasubramanian V. Hypofractionated hybrid radiotherapy techniques for synchronous bilateral breast cancer. Asian Pac J Cancer Prev. 2021;22(12):3933–3939. doi: 10.31557/APJCP.2021.22.12.3933.
   PubMedGoogle Scholar
• Balaji K, Yadav P, BalajiSubramanian S, et al. Hybrid volumetric modulated arc therapy for chest wall irradiation: for a good plan, get the right mixture. Phys Med. 2018;52:86–92. doi: 10.1016/j.ejmp.2018.06.641.
   PubMed Web of Science ®Google Scholar
• Sathiyaraj P, Manikandan PS, Varatharaj C, et al. Dosimetric evaluation of hybrid and volumetric-modulated arc therapy plan for left-sided chest wall irradiation in Monaco treatment planning system. J Cancer Res Ther. 2022;18(6):1728–1732. doi: 10.4103/jcrt.JCRT_707_20.
   PubMed Web of Science ®Google Scholar
• Aly MM, Glatting G, Jahnke L, et al. Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques. Radiat Oncol. 2015;10:139. doi: 10.1186/s13014-015-0452-2.
   PubMed Web of Science ®Google Scholar
• Venjakob A, Oertel M, Hering DA, et al. Hybrid volumetric modulated arc therapy for hypofractionated radiotherapy of breast cancer: a treatment planning study. Strahlenther Onkol. 2021;197(4):296–307. doi: 10.1007/s00066-020-01696-8.
   PubMed Web of Science ®Google Scholar
• Spruijt KH, Dahele M, Cuijpers JP, et al. Flattening filter free vs flattened beams for breast irradiation. Int J Radiat Oncol Biol Phys. 2013;85(2):506–513. doi: 10.1016/j.ijrobp.2012.03.040.
   PubMed Web of Science ®Google Scholar
• Bahrainy M, Kretschmer M, Jöst V, et al. Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique: influence of flattening filter-free beams. Strahlenther Onkol. 2016;192(5):333–341. doi: 10.1007/s00066-016-0960-5.
   PubMed Web of Science ®Google Scholar
• Sakthivel V, Kadirampatti Mani G, Mani S, et al. Estimating second malignancy risk in intensity-modulated radiotherapy and volumetric-modulated arc therapy using a mechanistic radiobiological model in radiotherapy for carcinoma of left breast. J Med Phys. 2017;42(4):234–240. doi: 10.4103/jmp.JMP_89_17.
   PubMedGoogle Scholar
• Kumar L, Kishore V, Bhushan M, et al. Impact of acuros XB algorithm in deep-inspiration breath-hold (DIBH) respiratory techniques used for the treatment of left breast cancer. Rep Pract Oncol Radiother. 2020;25(4):507–514. doi: 10.1016/j.rpor.2020.04.011.
   PubMedGoogle Scholar
• Guebert A, Conroy L, Weppler S, et al. Clinical implementation of AXB from AAA for breast: plan quality and subvolume analysis. J Appl Clin Med Phys. 2018;19(3):243–250. doi: 10.1002/acm2.12329.
   PubMed Web of Science ®Google Scholar
• Joosten A, Matzinger O, Jeanneret-Sozzi W, et al. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment. Radiother Oncol. 2013;106(1):33–41. doi: 10.1016/j.radonc.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Saroj DK, Yadav S, Paliwal N. Does fluence smoothing reduce the complexity of the Intensity-Modulated radiation therapy treatment plan? A dosimetric analysis. J Med Phys. 2022;47(4):336–343. doi: 10.4103/jmp.jmp_81_22.
   PubMed Web of Science ®Google Scholar
• Fogliata A, De Rose F, Franceschini D, et al. Critical appraisal of the risk of secondary cancer induction from breast radiation therapy with volumetric modulated arc therapy relative to 3D conformal therapy. Int J Radiat Oncol Biol Phys. 2018;100(3):785–793. doi: 10.1016/j.ijrobp.2017.10.040.
   PubMed Web of Science ®Google Scholar
• Virén T, Heikkilä J, Myllyoja K, et al. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiat Oncol. 2015;10:79. doi: 10.1186/s13014-015-0392-x.
   PubMed Web of Science ®Google Scholar
• Yu PC, Wu CJ, Nien HH, et al. Tangent-based volumetric modulated arc therapy for advanced left breast cancer. Radiat Oncol. 2018;13(1):236. doi: 10.1186/s13014-018-1167-y.
   PubMedGoogle Scholar
• Karpf D, Sakka M, Metzger M, et al. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage. Radiat Oncol. 2019;14(1):156. doi: 10.1186/s13014-019-1363-4.
   PubMed Web of Science ®Google Scholar
• Engstrøm KH, Brink C, Nielsen MH, et al. Automatic treatment planning of VMAT for left-sided breast cancer with lymph nodes. Acta Oncol. 2021;60(11):1425–1431. doi: 10.1080/0284186X.2021.1983209.
   PubMed Web of Science ®Google Scholar